>
|
|
|
 |
SK̿, ڰ Žž ڸFDA
|
|
|
|
Է : 2019-11-22 09:24:56
|
|
|
|
|
|
žళߺ ӻ㰡 α , K-̿
۸ ڣ
SK 100% ȸ SK̿ ž (XCOPRI, ٸƮ) κ ġ ̱ FDA 㰡 Ҵ. ž žĺ ߱ ӻ , Ǹ 㰡 û(NDA, New Drug Application) FDA ̹ ѹα ʴ.
SK̿ ̱ SK̾ ð ǸŸ þ, 2020 2б ̱ ø ǥ ϰ ִ.
2001 ӻ 㰡 FDA ž Ǹ 㰡 ȹϿ. ĺ ռ ȭչ 2,000 ̻, ̱ FDA žǸ㰡 û ۼ ڷḸ 230 Ѵ. 迡 ڷ FDA ž ʴ , ѹα ܰ ø ϰ ִ.
ߺ 㰡, ̱ ѱ SK̿ ̹ SK̿ ߽Ű(CNS, Central Nervous System) о ȯ ž ߱, ȭ ۷ι ŵ쳪 ʼ ̶͡, SK̿ R&D Ұ .
̱ 漾(CDC) ֽ 迡 , 2 ų Ӱ ް , ȯ 60% ġ ص ӵǰ ִ.
̹ 㰡 1-3 ġ ӿ κ ʴ ȯڵ 2 ߸Ͱ ӻ Ը ٱ ¶ ӻ ̷. ̱ ǽõƴ. 迡 뷮 ǹϰ Ÿ.
6ְ Ⱓ ̾ 6ְ Ⱓ ù ° ӻ(Study 013) ִ 200mg ȯڵ(n=113) ߾Ӱ 56% , (n=108) 22% Ͱ ǹ Ÿ.
6ְ Ⱓ ̾ 12ְ Ⱓ ̷ ° ӻ(Study 017) 100mg(n=108), 200mg(n=109), 400mg(n=111) ȯڵ ߾Ӱ 36%, 55%, 55% , 24% (n=106) ǹ .
Ӹ ƴ϶ ӻ 迡 ġ Ⱓ ǹ ȯڵ ۼҽǡ . Ⱓ ߿ ʴ ۼҽǡ ȯ ϻ ưٴ ǹ, ų ִ ߿ ҷ ž ÿ ߿ ǥ Ƶ鿩 ִ.
ù ° ӻ м ϸ ġ Ⱓ 9% ۼҽ ̴ ݸ, 28% ȯڵ ۼҽ . ° ӻ(Study 017) Ⱓ 100mg, 200mg, 400mg ȯڵ鿡 4%, 11%, 21% ۼҽ , 1% Ǵ Ÿ.
ӻ ʶǾ ۽ コ Ű& Ĺ Ű ۽ ճ(Jefferson Comprehensive Epilepsy Center) ̻ Ű Ŭ (Michael Sperling) ڻ ǻ κ ӵǴ ȯڵ鿡 ȿ ġ ְ ̶͡, ȯڵ鿡 ǹ ְ Ͽ, Ϻ ȯڵ鿡 ҽ Ÿ ſ ̴. ߴ.

, SK̿ ܿ FDA 7 ̱ 忡 Ǹŵǰ ִ ֽž (и: ָ) FDA ž(ڰ ) 2 ϰ ִ.
(yjun89@mdtoday.co.kr)
ũ 彺! ũ ڿܼ Ѵٰ?
<ǰ ̴ ѹα ǥ Ƿ, ǰ Ź , >
|
|
|
|
|
|